Search results for: 'partnering agreements with actavis formerly watson pharmaceuticals 2004 221b'
- Related search terms
- Partnering
- Partnering Agreement With
- Partnering Terms and Agreements in Diagnostics
- Partnering Agreements with Actavis (formerly Watson Pharmacueticals) 2009-2014
- partnering agreements with optimer pharmaceutical 221b 221b
-
Current Agreements 12 Month AccessNovember 2024$5,995.00Powerful Intelligence for Dealmakers...
Leading deals and alliances database for the life sciences sector
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2024November 2024$3,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
CP Knowledge CenterOctober 2024$35,995.00The All In One Partnering Intelligence Platform
Get unlimited access to our partnering report library conveniently and easily, while maximizing your time and budget
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Distribution Deals in Diagnostics 2016-2024September 2024$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Genomic Collaboration and Licensing Deals 2018-2024November 2024$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More -
Infectious Diseases Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More
